Corex
16.07.2015

COREX LOGISTICS COMPANY SERVING CIS COUNTRIES IS WORKING TO IMPROVE CUSTOMS PROCEDURES

corexnews
COREX LOGISTICS COMPANY SERVING CIS COUNTRIES IS WORKING TO IMPROVE CUSTOMS PROCEDURES
COREX LOGISTICS COMPANY SERVING CIS COUNTRIES IS WORKING TO IMPROVE CUSTOMS PROCEDURES

Clinical Trial Logistics materials for clinical trials is a small but very important part of developing, marketing and introducing new effective LP. Any error related to improper storage, transportation or late delivery of investigational drugs, can not only affect the results of the study but lead to multi-million dollar losses to the company or manufacturer and also may have a devastating health impacts for patients. In order to minimize such risks, companies are turning to specialized logistics companies.

Currently some problems exist in the Russian Logistics Market, said Konstantin Melnikov, Managing Director at COREX.

The full version of the article is available: http://www.pharmvestnik.ru/publs/lenta/interjvju/beg-na-vremja-s-prepjatstvijami.html#.VcIi1ZOqpBc 
Back to the list

Industry insights

CPhI Worldwide 2018

COREX representatives will be attending CPhI Worldwide 2018.

Annual results 2019 of CT market: ACT...

The Association of Clinical Trials Organizations (ACTO) (Russia) recently published an overview of clinical trials market in 2019.

Clinical trials and delivery in post-...

The pharmaceutical industry has faced numerous challenges since the beginning of 2021 including the rush to supply COVID-19 vaccines. The start of the year also saw the departure of the UK from the EU and theEuropean Medicines Agency (EMA). The Medicines and Healthcare Products Regulatory Agency (MHRA) is now fully in charge of all regulatory matters, oversight of clinical research and approval of medicines.

CONTACT US

We’re here to help.
Email us at info@corex-depot.com or use our feedback form to send us your question.

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy. Read More.